BioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025
Rhea-AI Summary
BioLife Solutions, a key player in the cell and gene therapy (CGT) market, has announced its upcoming first quarter 2025 financial results release and conference call schedule. The company, which specializes in bioproduction products and services, will release its Q1 2025 results after market close on Thursday, May 8, 2025.
The company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) on the same day. Management will present the financial results and provide a business update. Investors and interested parties can access the webcast through the company's Investor Relations page or join via phone using the toll-free numbers: 1-877-344-7529 (domestic) or 1-412-317-0088 (international).
A replay of the webcast will be available approximately two hours after the call and will remain accessible on the investor relations website for 90 days.
Positive
- BioLife maintains its position as a leading supplier in the growing cell and gene therapy market
Negative
- None.
News Market Reaction – BLFS
In the trading session that priced this news, BLFS declined 2.43%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-877-344-7529 or 1-412-317-0088 for international callers. A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.
About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.
Media & Investor Relations | ||
At the Company Troy Wichterman | ||
Chief Financial Officer | ||
(425) 402-1400 | ||
twichterman@biolifesolutions.com
Investors Alliance Advisors IR Jody Cain (310) 691-7100 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-first-quarter-2025-financial-results-and-business-update-on-may-8-2025-302441713.html
SOURCE BioLife Solutions, Inc.